PEPTIDE
Verified ComparisonLast updated: 18 March 2026

Fragment 176-191 vs Tirzepatide

Fragment 176-191 is a lipid-metabolism-specific HGH fragment. Tirzepatide is a metabolic peptide addressing broader appetite and insulin.

Compound A

HGH Fragment 176-191

Metabolic

Evidence
3.5/ 5
B

Compound B

Tirzepatide

Metabolic

Evidence
4.6/ 5
A
Editor's note
Tirzepatide has stronger weight loss and approval; Fragment 176-191 is lipid-selective.
CriterionHGH Fragment 176-191Tirzepatide
MechanismHGH C-terminal lipid effectsDual GLP-1/GIP agonism
Metabolic specificityLipid-focusedAppetite/insulin focused
Weight-loss potencyModerate (lipid)High (comprehensive)
Regulatory approvalInvestigationalApproved
Clinical evidenceLimitedExtensive

Frequently asked questions

Tirzepatide for approved/clinical; Fragment 176-191 for lipid-selective research.

Want to read the full reviews?

Read HGH Fragment 176-191 reviewRead Tirzepatide review